NCT00345033View on ClinicalTrials.gov

Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the Treatment of People With Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2010

Conditions
SchizophreniaInsulin Resistance
Interventions
DRUG

Aripiprazole

15-mg dose once a day for 8 weeks

DRUG

Placebo

1 tablet placebo dose once a day for 8 weeks

Trial Locations (1)

02114

Massachusetts General Hospital Schizophrenia Program, Boston

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Massachusetts General Hospital

OTHER

NCT00345033 - Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the Treatment of People With Schizophrenia | Biotech Hunter | Biotech Hunter